Close
Close
Treatment Database
N-methyl-4-({4-[({3-methyl(methylsulfonyl)aminopyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride
Trade Name not avaiable
Orphan Indication Ovarian cancer
EU Market Approval
EU Designation Date 15-01-2015
Sponsor TMC Pharma Services Ltd
More about Ovarian cancer
Free Newsletter
Related Videos
by Abidemi Uruejoma
965 views